creating value for
Life Science & Chemicals

We know the challenges of your industry

The pressure on companies in the life science market to be innovative, to invest and to satisfy regulations is relentless. To ensure profitability and competitiveness in the long term, they must continuously optimize their processes, costs and compliance management.

At the same time, digitalization also holds new opportunities. Collaborations and cooperations in global value creation networks are a prime example. Not to mention the new prospects the integration of digital and mobile technologies, as well as the development of innovative multi-channel and customer-centricity concepts have opened up. The experts at the msg group help you make the most of these opportunities through sound strategic consulting and competent IT support. Build on our expertise.

 

Advancing Industry Leaders: msg industry advisors steigern die Leistungsfähigkeit von Unternehmen entlang der Wertschöpfungskette der produzierenden Industrie. Als Experten der msg-Gruppe für den Life Science & Healthcare Markt ist ihr Ziel erreicht, wenn sie ihre Kunden erfolgreicher gemacht haben.

 

  • Heraeus: Carve-out in Record Time: “We were able to complete a business-critical migration of an SAP environment as part of a company-wide reorganization in the regulatory environment and do so within the requested timeframe and with the necessary quality thanks to the support of msg – without any impairment of the product quality or patient security.”
     
  • Pfizer: Compliance Governance Excellence: “As part of a long-term collaboration with msg, we established a methodology for ensuring rule-compliance that is specifically tailored to Pfizer GmbH’s needs and are able to follow an approach of continuous improvement. Decisive for the success of these measures was the support we received from msg, especially the specialized business and method competence of the msg consultants we worked with. These process modifications allow us to ensure compliance with internal company instructions and local regulations. We were able to do so with optimized effort and the results were commended by Pfizer Global Security.”

  • Operationalization of company strategies and business model innovation

  • Optimization and standardization of core and supporting processes as part of effective Business Process Management
  • Analysis and optimization of pharmaceutical production processes
  • Introduction and implementation of concepts and methods for company-wide compliance
  • Analysis and optimization of the logistics processes along the entire value chain
  • Project management for complex and critical projects
  • Coaching and strategic employee qualification

 

msg News

msg for banking

In der dritten Folge der Audioreihe Impuls „Risk & Regulatory Reporting“ sprechen wir über das in der Banksteuerung zentrale Thema ICAAP (Internal Capital Adequacy Assessment Process). Was hat sich im ICAAP in letzter Zeit getan? Welche konkreten Herausforderungen haben LSIs? Und wie sieht die Zukunft des ICAAPs aus? Diese und weitere…

msg for banking

Die EBA-Leitlinien formulieren Mindeststandards bzw. Referenzmethoden zur Integration von ESG-Risiken in Finanzinstitute. Damit Institute ausreichend widerstandsfähig gegenüber den negativen Auswirkungen von ESG-Faktoren bleiben, müssen in der EU ansässige Institute in der Lage sein, diese systematisch zu identifizieren, zu messen und zu…

msg viewpoints

The pharmaceutical industry must remain capable of acting in the event of cyber attacks. Stable business continuity management helps with this.

msg viewpoints

What role does the digital twin play in achieving sustainability goals? And what hurdles are there when using the digital twin?

msg survey

To what extent is generative AI already being used in large German companies? What are the main use cases? msg conducted an online survey together with the market research institute INNOFACT - with exciting results.

msg news

A remarkable rise: msg has climbed to fourth place in the current Lünendonk ranking of "Leading IT Consulting and System Integration Companies in Germany" for the first time — an improvement of one place compared to the previous year.

msg viewpoints

The rapid development of generative AI and large language models has ushered in a new era that is sweeping through our world. But to what degree has this revolution already impacted the corporate landscape in Germany? In this Viewpoint interview, Mark-W. Schmidt, Head of AI at msg, sheds light on the impact of GenAI on the economy and provides insights into the current msg study on the use of GenAI

msg viewpoint

A modern state needs a digital administration. The state's ability to act and control its data must be guaranteed at all times – even in crisis situations. The current government's coalition agreement clearly emphasizes digital sovereignty as a key objective of state intervention. As most IT systems today are based on cloud technologies, it is crucial for the public administration that these systems are sovereign. Werner Achtert, business area lead Public Sector at msg, explains what a suitable framework for the public sector's cloud transformation could look like in this viewpoint interview.